PTCT

Ptc Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 9/10
  • Value↑ 7/10
Ptc Therapeutics sales and earnings growth
PTCT Growth
Great
  • Revenue Y/Y↑ 114.51%
  • EPS Y/Y↑ 281.40%
  • FCF Y/Y↑ 999.81%
Ptc Therapeutics gross and profit margin trends
PTCT Profitability
Great
  • Gross margin ↑ 97.30%
  • EPS margin↑ 39.40%
  • ROIC 5Y↑ -3.57%
Ptc Therapeutics net debt vs free cash flow
PTCT Risk
Great
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 5.6

Ptc Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗